TOPAMAX (topiramate) Initiated as Monotherapy in Epilepsy (TIME): A multicenter, outpatient, open-label, study to evaluate the dosing, effectiveness and safety of TOPAMAX as monotherapy in the treatment of epilepsy in clinical practice

Trial Profile

TOPAMAX (topiramate) Initiated as Monotherapy in Epilepsy (TIME): A multicenter, outpatient, open-label, study to evaluate the dosing, effectiveness and safety of TOPAMAX as monotherapy in the treatment of epilepsy in clinical practice

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Sep 2009

At a glance

  • Drugs Topiramate (Primary)
  • Indications Epilepsy
  • Focus Therapeutic Use
  • Acronyms TIME
  • Sponsors Janssen Research & Development
  • Most Recent Events

    • 22 Sep 2009 Actual patient number (409) added as reported by ClinicalTrials.gov.
    • 08 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top